Search company, investor...

Compare Janus Pharmaceuticals vs Zevra Therapeutics

Customers evaluate the quality of Janus Pharmaceuticals's products using the following success metrics.

Overview

Janus Pharmaceuticals is 20 yrs old and is based in United States.

Janus Pharmaceuticals Inc. (Janus) is a specialty pharmaceutical company identifying, acquiring and aggressively developing topical prescription products for treatment of skin infections. Determined to be the "Dermal Alternative", Janus has already established a strong intellectual property portfolio for topical anti-infective compounds that would be rapidly commercialized through fast regulatory pathways. Led by an accomplished management team and board located in the US and Japan, Janus has trans-Pacific network and resources in the biopharmaceutical industry.

Zevra Therapeutics is 18 yrs old and is based in United States.

Zevra Therapeutics (NASDAQ CM: ZVRA) is a biopharmaceutical company, which focuses on the discovery and development in the field of New Chemical Entities (NCEs), rare diseases, and the central nervous system. The company offers Ligand Activated therapy to assist in the qualities of approved drugs. The company also offers products, such as KP415, and KP484. It was formerly known as KemPharm and changed its name to Zevra Therapeutics in February 2023. The company was founded in 2006 and is based in Kissimmee, Florida.

Country

United States

Demo Video

Demo not available because Janus Pharmaceuticals has not claimed their profile.

Work for Janus Pharmaceuticals? Show off your product.

Demo not available because Zevra Therapeutics has not claimed their profile.

Work for Zevra Therapeutics? Show off your product.

Leadership

Saman Ahmad Nasrollahi (Chief Executive Officer)

See all 2 people

Travis C Mickle (Chief Executive Officer)

See all 5 people

Funding

Janus Pharmaceuticals last raised $2M on 4/7/2005.
Zevra Therapeutics last raised $55.99M on 4/16/2015.

Investors

Nexus Finance, Private Equity Japan

See all 4 investors

Deerfield Management, DeWaay Investment Partners

See all 4 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Janus Pharmaceuticals has not claimed their profile.

Work for Janus Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Janus Pharmaceuticals?

Claim your profile now.

Information not available because Zevra Therapeutics has not claimed their profile.

Work for Zevra Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Zevra Therapeutics?

Claim your profile now.